Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1861 of 6351
-
Could a lesson on cancer risks save lives in underserved communities?
Prevention Recruiting nowThe University of California Davis, Comprehensive Cancer Center's (UCDCCC) Office of Community Outreach and Engagement (OCOE) serves the 19 catchment counties which approximately consists of 5 million residents. Currently, the overall catchment population cancer screening rates f…
Sponsor: University of California, Davis • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
LYNPARZA safety checked in BRCA breast cancer survivors
Disease control CompletedTo evaluate the frequency of bone marrow suppression Adverse Drug Reactions (ADRs) in patients with BRCA mutated HER2 negative high recurrent risk breast cancer treated with LYNPARZA for adjuvant treatment in the actual post-marketing use.
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a wearable sensor replace the glucose drink test for diabetes in pregnancy?
Diagnosis CompletedThe purpose of this study is to evaluate whether Continuous glucose monitoring (CGM) for diagnosis of gestational diabetes mellitus (GDM) improves maternal and neonatal outcomes related to GDM and to evaluate whether CGM for GDM diagnosis reduces the health system costs for mothe…
Sponsor: The University of Texas Health Science Center, Houston • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Experimental cocktail aims to tackle recurrent head and neck cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability and maximum tolerated dose of tislelizumab in combination with pamiparib plus chemoradiotherapy (chemotherapy and radiation) in individuals with recurrent head and neck cancer, which means that the person's cancer …
Phase 1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Virtual rehab could be as good as In-Person for heart recovery
Disease control CompletedThe proposed trial is a multiphase, multicenter, non-inferiority, hybrid type 1 effectiveness, randomized controlled trial to test an innovative virtual world-based cardiac rehabilitation (CR) program, "Destination Cardiac Rehab". The primary objectives of this study are to asses…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could a vending Machine-Style kiosk curb HIV and overdose deaths in rural america?
Disease control OngoingThis study will test the effectiveness, implementation outcomes, and cost effectiveness of a locally-tailored, health kiosk to reduce overdose, hepatitis C, and HIV risk behavior and improve linkage to care in rural Appalachia. The proposed project will take place in two counties…
Sponsor: April M Young • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Could short bursts of low oxygen help spinal cord injury patients move better?
Symptom relief CompletedSpinal cord injury (SCI) is a devastating disability with physical, social and vocational consequences. Owing to its overwhelming complications, the cost of treatment and rehabilitation increases constantly. Persons with spinal cord injury are always dependent on their families i…
Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New drug tegavivint takes on tough lymphoma in early trial
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of tegavivint in treating patients with large b-cell lymphomas that has come back (relapsed) or does not respond to treatment (refractory). Tegavivint may stop the growth of cancer cells by blocking some of the enzy…
Phase 1 • Sponsor: Lapo Alinari • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can DNA tests match more pancreatic cancer patients to the right drugs?
Knowledge-focused OngoingThis is a prospective, multi-centre, translational and observational study. Two cohorts of patients with pancreatic ductal adenocarcinoma (PDAC) are eligible to enroll 1) Upfront resectable PDAC 2) Advanced (unresectable PDAC or metastatic). Patients will have tissue either at re…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
New eye drops could replace reading glasses for presbyopia
Symptom relief CompletedPhase 3 Efficacy Study to evaluate the Safety and Efficacy of LNZ100 \& LNZ101 for the Treatment of Presbyopia
Phase 3 • Sponsor: LENZ Therapeutics, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Fasting at night may cut cancer risk in people with blood disorder precursors
Disease control CompletedThis is a 4-month randomized trial of a prolonged nightly fasting intervention (PROFAST) in 40 overweight and obese individuals with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), and smoldering waldenstrom macroglobulinemia (SWM). T…
Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Moms and teens team up to fight obesity in black girls
Prevention OngoingBlack Girls Move is a school-linked daughter/mother physical activity and dietary behavior program, with 9th and 10th grade students. This program is designed to prevent obesity in Black adolescent females and thus aligns with the NIH mission to enhance health, lengthen life, and…
Sponsor: Rush University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
New drug hope for stem cell transplant complication
Disease control Recruiting nowBackground: Chronic graft-versus-host disease (cGVHD) is an immune system disorder that can occur in people who have had a stem cell transplant. cGVHD can affect multiple organs and increase risk of disability and death. New treatments are needed to treat cGVHD after stem cell t…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New study tests if focused ultrasound can replace prostate removal surgery
Disease control Recruiting nowMedico-Economic Randomized Trial comparing Focal HIFU Treatment to Radical Prostatectomy in Patients with Favorable Intermediate Risk Prostate Cancer
Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Minimally invasive stent graft for aortic aneurysm under Real-World scrutiny
Disease control Recruiting nowThe Minos™ Abdominal Aortic Stent-Graft and Delivery System is a medical device designed to treat abdominal aortic aneurysms using a minimally invasive procedure. The device is placed inside the aorta through blood vessels, usually accessed through small incisions in the groin. T…
Sponsor: Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Can a simple protein tame Sepsis's fiery inflammation?
Disease control CompletedThere is currently no uniform target for serum albumin levels in some pathological conditions, but recent studies have shown that serum albumin concentrations, disease severity, and mortality rates have been linked. Although the exact mechanism is unclear, serum albumin levels ma…
Early phase 1 • Sponsor: University of Pecs • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Hope for young CF patients: new drug may ease sinus troubles
Symptom relief CompletedCystic fibrosis is a multi-organ disease. It most often results from a genetic mutation, the delta F508 mutation, which prevents the expression of the CFTR 'régulateur de conductance transmembranaire de la fibrose kystique) protein. If the poor prognosis of the disease is correla…
Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated Jun 26, 2026 18:45 UTC
-
Hope for rare wolfram syndrome: drug aims to slow diabetes progression
Disease control OngoingThis study is an open label Phase II study to evaluate the safety and efficacy of AMX0035 in adults with Wolfram syndrome.
Phase 2 • Sponsor: Amylyx Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a brain steroid lift depression in HIV patients?
Symptom relief Recruiting nowThis study will determine the effects of pregnenolone on brain function, inflammation and depressive symptoms in people with HIV who have depression. Participants in this study will receive a pill of either pregnenolone or placebo, and can stay on their current antidepression med…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 15:37 UTC
-
Can a hormone supplement tame asthma?
Disease control CompletedThis is a study to look at pharmacokinetic levels of different doses of slow release DHEA in subjects with asthma.
Phase 1/2 • Sponsor: Indiana University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC